The FDA has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra (vutrisiran), is made by Alnylam Pharmaceuticals and is used to treat protein ...

Alzheimer's Disease can seem like a tragic inevitability for those who have rare genetic forms of the disease. The ...

If you're someone who is at high risk of developing dementia or Alzheimer's disease, it can be pretty emotionally and mentally draining, especially if you feel like there's very little you can do to ...

The drug, gantenerumab, was abandoned by its developers, but subsequent anti-amyloid drugs lecanemab ( Leqembi) and donanemab ...

Vaccination against shingles may reduce dementia risk, suggesting viral infections play a crucial role in Alzheimer’s disease ...

During the early stages of the disease, the amyloid protein can build-up as plaques in the brain. Brain immune cells, called microglia, are located nearby amyloid plaques and become activated in the ...

Now, American scientists say women who already have a build-up of one toxic protein — amyloid — in the brain accumulated another protein — tau — at a faster rate than their male counterparts.

An experimental drug appears to reduce the risk of Alzheimer’s disease in people destined to develop the condition in middle ...

a potentially fatal disease that causes the rogue protein amyloid to build up in organs like the heart and kidneys. Alexion teamed up with Caelum on CAEL-101 in 2019, taking a minority stake in ...

The findings provide new evidence to support the so-called amyloid hypothesis of Alzheimer’s disease, which posits that the first step on the road to dementia is the build-up of amyloid plaques ...

The findings provide new evidence to support the so-called amyloid hypothesis of Alzheimer's disease, which posits that the first step on the road to dementia is the build-up of amyloid plaques in ...